(Total Views: 340)
Posted On: 09/30/2019 12:09:06 PM
Post# of 36568
Pokey, I think you are on the right track. Since 12/3/2018 Generex has provided us with some financial engineering "candy", for want of a better description. As each milestone approached, interest was generated on a sugar high. Those days are over, give or take the benefits of the newly retired shares.
Generex is thinly traded. Outside of we few and some limited others, no one knows anything about the company. What they do know is colored by the collapse of a company with a market cap in the 100's of $millions that was delisted from NASDAQ and experienced an unheard of 1000:1 R/S.
I think the potential of Generex is huge. But potential is what gets people fired. They have to deliver uplisting, earnings, and solid quarterly reports over an extended period. The company needs to be followed by reputable analysts who provide honest assessments that the major houses will follow. I am optimistic about the possibilities for Generex, but I don't expect to see any magic soon unless there is something extremely positive in the 10-K or a positive surprise between now or during the CC.
Generex has put on its big boy pants and no more having dessert before dinner. It has to put some meat on the bone. Tofu won't do. Those of us on this board are some 90% sure they will be, but we've invested in a highly speculative biotech OTC stock, not a CD. There are tens of millions of CD people out there who won't even give us a sniff unless Generex gives them a reasons to.
Generex is thinly traded. Outside of we few and some limited others, no one knows anything about the company. What they do know is colored by the collapse of a company with a market cap in the 100's of $millions that was delisted from NASDAQ and experienced an unheard of 1000:1 R/S.
I think the potential of Generex is huge. But potential is what gets people fired. They have to deliver uplisting, earnings, and solid quarterly reports over an extended period. The company needs to be followed by reputable analysts who provide honest assessments that the major houses will follow. I am optimistic about the possibilities for Generex, but I don't expect to see any magic soon unless there is something extremely positive in the 10-K or a positive surprise between now or during the CC.
Generex has put on its big boy pants and no more having dessert before dinner. It has to put some meat on the bone. Tofu won't do. Those of us on this board are some 90% sure they will be, but we've invested in a highly speculative biotech OTC stock, not a CD. There are tens of millions of CD people out there who won't even give us a sniff unless Generex gives them a reasons to.
(4)
(0)
